Relation of serum uric acid to cardiovascular disease
Audrey H Wu1, James D Gladden2, Mustafa Ahmed3
1Cardiovascular Center, University of Michigan Health Systems, Ann Arbor, MI, USA.
Insights
Serum uric acid is complexly linked to cardiovascular disease, potentially acting as a risk marker or causative agent. Elevated levels correlate with adverse outcomes and increased risk for various heart conditions.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Clinical Biochemistry
Background:
- The relationship between serum uric acid and cardiovascular disease (CVD) is intricate and not fully understood.
- Serum uric acid levels are influenced by biological factors and are associated with conditions like hypertension, dyslipidemia, obesity, and impaired glucose metabolism, which contribute to CVD.
- Existing literature suggests a link between elevated serum uric acid and adverse health outcomes, including mortality in the general population.
Purpose of the Study:
- To review and synthesize recent literature on the association between serum uric acid levels and cardiovascular disease.
- To explore the potential roles of serum uric acid as a risk marker, causative agent, or both in CVD development and progression.
Main Methods:
- Systematic review of published literature.
- Analysis of studies investigating the correlation between serum uric acid and various cardiovascular conditions and outcomes.
Main Results:
- Serum uric acid is associated with an increased risk of developing coronary heart disease, heart failure, and atrial fibrillation.
- In patients with established systolic heart failure, higher serum uric acid levels correlate with greater disease severity and increased mortality risk.
- Serum uric acid levels are linked to hypertension, dyslipidemia, obesity, and impaired glucose metabolism, all contributing factors to cardiovascular disease.
Conclusions:
- The association between serum uric acid and cardiovascular disease is multifaceted, with evidence suggesting it may serve as both a risk indicator and a potential contributor.
- Further research is needed to determine if therapeutic interventions targeting serum uric acid levels can positively impact clinical cardiovascular outcomes.
Abstract:
This review summarizes recent published literature on the association between serum uric acid and cardiovascular disease, a relationship which is complex and not fully elucidated. Uric acid may be a marker for risk, a causative agent in cardiovascular disease, or both. Various biologic factors can influence serum uric acid levels, and serum uric acid level itself is closely related to conditions such as hypertension, dyslipidemia, obesity, and impaired glucose metabolism, that contribute to cardiovascular disease pathophysiology. Serum uric acid levels have been found to be associated with adverse outcomes, including mortality, in the general population. In addition, serum uric acid is associated with increased risk for incident coronary heart disease, heart failure, and atrial fibrillation. In the setting of established systolic heart failure, serum uric acid is positively associated with disease severity and mortality risk. Whether targeting treatment based on uric acid levels might affect clinical outcomes is still being studied.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Serum Studies: Renal Function Tests
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
